je.st
news
Leerink Swann Lowers Dyax Corp. Price Target to $7.00
2014-05-04 02:35:39| Biotech - Topix.net
The firm currently has a "market perform" rating on the stock. Leerink Swann's price objective would indicate a potential upside of 6.06% from the company's current price.
Tags: price
target
corp
lowers
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||